Get startedLog in
    Picture of Glenmark Pharmaceuticals logo

    GLENMARK — Glenmark Pharmaceuticals News Story

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Glenmark Pharma jumps on unit's cancer licensing deal with AbbVie

    Picture of Glenmark Pharmaceuticals logoGlenmark Pharmaceuticals
    11/07/2025 04:48
    Corrects to add "treatment" in headline

July 11 (Reuters) - Shares of Glenmark Pharmaceuticals GLEN.NS jumped 10% in early trade on Friday, a day after a unit of the Indian drugmaker signed an exclusive licensing deal with U.S. peer AbbVie ABBV.N for its cancer treatment.

 (Reporting by Hritam Mukherjee in Bengaluru; Editing by Sonia Cheema)

 ((Hritam.Mukherjee@thomsonreuters.com; X: @MukherjeeHritam;))

    Recent news on Glenmark Pharmaceuticals

    See all news